Staph infection, called methicillin-resistant Staphylococcus aureus or commonly known as MRSA.
This antibiotic-resistant staph infection is highly contagious. The CC Treatment has shown remarkable success in treating this infection, additional information can be reviewed here (more…)
The Cancer Cell (CC) Formula is an experimental treatment that is currently being researched on cancer, infectious and other diseases.
This technology targets cells which do not follow the Krebs metabolic cycle by delivering a lethal dose of minerals (zinc and copper) to those cells. Because cancer cells follow an anaerobic, non-Krebs metabolism, it is predicted to target cancer cells precisely.
Between 5 and 10 percent of all patients contract at least one hospital-acquired infection.
Also known as a healthcare-associated infection or nosocomial infection—during their stay in an acute care hospital. According to estimates from the National Nosocomial Infections Surveillance (NNIS) system, in 2002, approximately 1.7 million cases of HAIs and 99,000 associated deaths occurred in U.S. hospitals, leading to extra costs of up to $6.5 billion each year.
Reports and agencies are releasing the newest problem in the world’s health as the number one issue facing this era “Antimicrobial Resistance”.
In a consciously alarming report released by WHO, the agency said, “Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.”
The CC Formula can treat mutated cells, non-functioning cells.
And non-typical cell diseases as well as viral, bacterial, and fungal diseases in conjunction with or without other drugs, surgery, chemotherapy, or radiation.
Conventional drug therapies have limitations.
To breakthrough, the medical industry is devoting time and money to cellular biology and developing treatments that effectively shut down genes tied to life-threatening diseases and genetic disorders like MRSA.
SARM, siglas de Staphylococcus Aureus Resistente.
SARM es exactamente lo que su nombre dice que es, se trata de una infección por estafilococo bacteriana que tiene una resistencia a la medicación, meticilina.
The CC Treatment has shown success with MRSA. Here is a brief description of staphylococcus aureus and MRSA.